Previous work has shown that while serum BCMA (sBCMA) level is present in healthy donors, the levels are higher among those with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and MM [8, 9]. This evidence concerns the gene TNFRSF17 and AL amyloidosis.